Cancer is the leading cause of death worldwide. Currently available therapies are not adequate for all cancer types, since that the investigation of new approaches in treatment is extremely important. The rapid advancement of nanotechnology and the development of nanomaterials enable the development of sophisticated strategies for targeted cancer therapy. Nanoparticles can improve the pharmacokinetic and pharmacodynamic properties of conventional therapeutics and optimize their efficacy.
Our previous and planned research is focused on several different approaches in the application of nanoparticles. The basic approach involves monitoring the effects of the nanoparticles themselves (TiO2, CeO2, BiFeO3 etc.) on the growth of cancer cells in vitro. Their effects on the induction and regulation of different types of cell death such as apoptosis and autophagy will be investigated. Molecular mechanisms involved in cell cycle regulation and cell senescence will also be investigated. Further studies will include the action of metallo-complexes as antitumor agents, since nanoparticles, in addition to their direct action on tumor cells, can also serve as carriers of other agents. A special direction of research refers to the use of nanoparticles as photosensitizers for photodynamic therapy, thanks to the phototoxic effect they have on cancer cells after activation by light.
In addition to contributing to fundamental knowledge in elucidating the signaling pathways involved in the action of nanoparticles and metal complexes, the planned research will also have great potential in translational research into new approaches in cancer treatment.